Jerry Smith

Associate Professor


Personal Summary

Dr. Smith completed a B.S. degree in Pharmacy from the University of Georgia in Athens, GA (1967) and a Ph.D. in Pharmacology (1977) from the University of Mississippi in Oxford.  After graduate school he accepted a position at The University of Montana and has been here since 1977.

Field of Study

Work in my lab focuses on:

  • Myocardial Preconditioning and Ischemia-Reperfusion Injury
  • Diabetic Modification of Cardiovascular Function
  • Drug Metabolism & Cytochrome P-450 Isozymes
  • Interactions of Soluble Fibers and Cardioactive Drugs
  • Perfluorohydrocarbons and Their Impact on Oxygen Deprivation
  • Energetics of CNS Cells Exposed to Potential Neurotoxins

Selected Publications

Smith, JR, Botchek, S, Manson, R, and Jaksha, J:  In Vitro interactions of selected soluble fibers with the cardiovascular drugs, nicotinic acid (Niacin) and pentoxifylline.  Proc. Western Pharmacology Society, 35:107-111, 1992.

Zhao, L, Smith JR, and Eyer, CL:  Effects of a 100% perfluorooctylbromide emulsion on ischemia/reperfusion injury following cardioplegia.  Biomat., Art. Cells, & Immob. Biotech.  23(4):513-517, 1995.

Tarr, BD, Fraser, BH, and Smith, JR:  Aminoguanidine prevents the negative inotropy associated with rabbits on high-fat, high-cholesterol diets.   Pharmaceutical Sciences 2:1-4,1996.

Elliott, GT, Comerford, ML, Smith, JR, and Zhao, L:  Myocardial ischemia/reperfusion protection using MPL-A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide.  Cardiovascular Research 32:1071-1080, 1996.

Zhao, L, Weber, PA, Smith, JR, Comerford, ML and Elliot ,GT:  Role of inducible nitric oxide synthase in pharmacologic "preconditioning" with monophosphoryl lipid A.  J. Molec. Cell. Cardiology 29:1567-1576, 1997.